nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—DRD2—Gilles de la Tourette syndrome	0.451	0.564	CbGaD
Nortriptyline—HTR2A—Gilles de la Tourette syndrome	0.349	0.436	CbGaD
Nortriptyline—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00577	0.0942	CbGeAlD
Nortriptyline—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00347	0.0566	CbGeAlD
Nortriptyline—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00169	0.0276	CbGeAlD
Nortriptyline—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.00163	0.0266	CbGeAlD
Nortriptyline—HTR6—nervous system—Gilles de la Tourette syndrome	0.00151	0.0247	CbGeAlD
Nortriptyline—HTR6—central nervous system—Gilles de la Tourette syndrome	0.00146	0.0238	CbGeAlD
Nortriptyline—CHRM5—nervous system—Gilles de la Tourette syndrome	0.00132	0.0216	CbGeAlD
Nortriptyline—CHRM4—brain—Gilles de la Tourette syndrome	0.00129	0.0211	CbGeAlD
Nortriptyline—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.00127	0.0208	CbGeAlD
Nortriptyline—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00121	0.0197	CbGeAlD
Nortriptyline—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00118	0.0193	CbGeAlD
Nortriptyline—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00116	0.019	CbGeAlD
Nortriptyline—HTR6—brain—Gilles de la Tourette syndrome	0.00116	0.0189	CbGeAlD
Nortriptyline—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00114	0.0186	CbGeAlD
Nortriptyline—HTR2C—midbrain—Gilles de la Tourette syndrome	0.00106	0.0174	CbGeAlD
Nortriptyline—CHRM5—brain—Gilles de la Tourette syndrome	0.00101	0.0165	CbGeAlD
Nortriptyline—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.00101	0.0165	CbGeAlD
Nortriptyline—ORM1—nervous system—Gilles de la Tourette syndrome	0.000973	0.0159	CbGeAlD
Nortriptyline—ORM1—central nervous system—Gilles de la Tourette syndrome	0.000937	0.0153	CbGeAlD
Nortriptyline—ADRA1B—brain—Gilles de la Tourette syndrome	0.000923	0.0151	CbGeAlD
Nortriptyline—CHRM2—nervous system—Gilles de la Tourette syndrome	0.000908	0.0148	CbGeAlD
Nortriptyline—ADRA1D—brain—Gilles de la Tourette syndrome	0.000903	0.0147	CbGeAlD
Nortriptyline—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000896	0.0146	CbGeAlD
Nortriptyline—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000875	0.0143	CbGeAlD
Nortriptyline—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.000874	0.0143	CbGeAlD
Nortriptyline—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000842	0.0137	CbGeAlD
Nortriptyline—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000829	0.0135	CbGeAlD
Nortriptyline—CHRM1—nervous system—Gilles de la Tourette syndrome	0.000826	0.0135	CbGeAlD
Nortriptyline—DRD2—midbrain—Gilles de la Tourette syndrome	0.000809	0.0132	CbGeAlD
Nortriptyline—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000798	0.013	CbGeAlD
Nortriptyline—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.000795	0.013	CbGeAlD
Nortriptyline—CHRM3—nervous system—Gilles de la Tourette syndrome	0.000739	0.0121	CbGeAlD
Nortriptyline—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000736	0.012	CbGeAlD
Nortriptyline—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.00073	0.0119	CbGeAlD
Nortriptyline—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.000712	0.0116	CbGeAlD
Nortriptyline—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000709	0.0116	CbGeAlD
Nortriptyline—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000703	0.0115	CbGeAlD
Nortriptyline—CHRM2—brain—Gilles de la Tourette syndrome	0.000694	0.0113	CbGeAlD
Nortriptyline—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000679	0.0111	CbGeAlD
Nortriptyline—HTR2C—brain—Gilles de la Tourette syndrome	0.000669	0.0109	CbGeAlD
Nortriptyline—DRD2—nervous system—Gilles de la Tourette syndrome	0.000665	0.0109	CbGeAlD
Nortriptyline—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000654	0.0107	CbGeAlD
Nortriptyline—ALB—brain—Gilles de la Tourette syndrome	0.000652	0.0106	CbGeAlD
Nortriptyline—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000641	0.0105	CbGeAlD
Nortriptyline—SLC6A4—brain—Gilles de la Tourette syndrome	0.000634	0.0103	CbGeAlD
Nortriptyline—CHRM1—brain—Gilles de la Tourette syndrome	0.000631	0.0103	CbGeAlD
Nortriptyline—Maprotiline—SLC6A3—Gilles de la Tourette syndrome	0.00058	0.066	CrCbGaD
Nortriptyline—CHRM3—brain—Gilles de la Tourette syndrome	0.000565	0.00922	CbGeAlD
Nortriptyline—HTR1A—brain—Gilles de la Tourette syndrome	0.000563	0.00919	CbGeAlD
Nortriptyline—SLC6A2—brain—Gilles de la Tourette syndrome	0.000558	0.00911	CbGeAlD
Nortriptyline—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000534	0.00871	CbGeAlD
Nortriptyline—HRH1—nervous system—Gilles de la Tourette syndrome	0.000525	0.00858	CbGeAlD
Nortriptyline—ADRA1A—brain—Gilles de la Tourette syndrome	0.000519	0.00847	CbGeAlD
Nortriptyline—DRD2—brain—Gilles de la Tourette syndrome	0.000509	0.0083	CbGeAlD
Nortriptyline—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000506	0.00826	CbGeAlD
Nortriptyline—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.000505	0.00824	CbGeAlD
Nortriptyline—PTGS1—nervous system—Gilles de la Tourette syndrome	0.000486	0.00794	CbGeAlD
Nortriptyline—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.000486	0.00793	CbGeAlD
Nortriptyline—PTGS1—central nervous system—Gilles de la Tourette syndrome	0.000468	0.00764	CbGeAlD
Nortriptyline—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000439	0.00716	CbGeAlD
Nortriptyline—Maprotiline—DRD2—Gilles de la Tourette syndrome	0.000432	0.0491	CrCbGaD
Nortriptyline—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000423	0.0069	CbGeAlD
Nortriptyline—Mianserin—DRD3—Gilles de la Tourette syndrome	0.000419	0.0477	CrCbGaD
Nortriptyline—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000406	0.00663	CbGeAlD
Nortriptyline—HRH1—brain—Gilles de la Tourette syndrome	0.000402	0.00656	CbGeAlD
Nortriptyline—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.0004	0.00653	CbGeAlD
Nortriptyline—Atomoxetine—SLC6A3—Gilles de la Tourette syndrome	0.000399	0.0454	CrCbGaD
Nortriptyline—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000391	0.00638	CbGeAlD
Nortriptyline—Cyclobenzaprine—HTR2A—Gilles de la Tourette syndrome	0.00039	0.0444	CrCbGaD
Nortriptyline—Mianserin—SLC6A3—Gilles de la Tourette syndrome	0.00039	0.0444	CrCbGaD
Nortriptyline—Epinastine—HTR2A—Gilles de la Tourette syndrome	0.000387	0.0441	CrCbGaD
Nortriptyline—CYP2E1—brain—Gilles de la Tourette syndrome	0.000386	0.0063	CbGeAlD
Nortriptyline—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000385	0.00628	CbGeAlD
Nortriptyline—Cyproheptadine—DRD2—Gilles de la Tourette syndrome	0.000383	0.0435	CrCbGaD
Nortriptyline—Chlorprothixene—DRD3—Gilles de la Tourette syndrome	0.000382	0.0434	CrCbGaD
Nortriptyline—PTGS1—brain—Gilles de la Tourette syndrome	0.000372	0.00607	CbGeAlD
Nortriptyline—HTR2A—brain—Gilles de la Tourette syndrome	0.000335	0.00548	CbGeAlD
Nortriptyline—Maprotiline—HTR2A—Gilles de la Tourette syndrome	0.000333	0.0379	CrCbGaD
Nortriptyline—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.000328	0.0373	CrCbGaD
Nortriptyline—CYP2D6—brain—Gilles de la Tourette syndrome	0.000306	0.00499	CbGeAlD
Nortriptyline—Cyproheptadine—HTR2A—Gilles de la Tourette syndrome	0.000296	0.0336	CrCbGaD
Nortriptyline—Mianserin—DRD2—Gilles de la Tourette syndrome	0.00029	0.033	CrCbGaD
Nortriptyline—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000287	0.0326	CrCbGaD
Nortriptyline—Chlorprothixene—DRD2—Gilles de la Tourette syndrome	0.000264	0.03	CrCbGaD
Nortriptyline—Amitriptyline—DRD3—Gilles de la Tourette syndrome	0.00026	0.0296	CrCbGaD
Nortriptyline—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.000244	0.0278	CrCbGaD
Nortriptyline—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000243	0.0277	CrCbGaD
Nortriptyline—Doxepin—DRD2—Gilles de la Tourette syndrome	0.000233	0.0265	CrCbGaD
Nortriptyline—Atomoxetine—HTR2A—Gilles de la Tourette syndrome	0.000229	0.0261	CrCbGaD
Nortriptyline—Mianserin—HTR2A—Gilles de la Tourette syndrome	0.000224	0.0255	CrCbGaD
Nortriptyline—Desipramine—DRD2—Gilles de la Tourette syndrome	0.000213	0.0243	CrCbGaD
Nortriptyline—Clomipramine—HTR2A—Gilles de la Tourette syndrome	0.000205	0.0233	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2A—Gilles de la Tourette syndrome	0.000204	0.0232	CrCbGaD
Nortriptyline—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.000189	0.0215	CrCbGaD
Nortriptyline—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000181	0.0206	CrCbGaD
Nortriptyline—Amitriptyline—DRD2—Gilles de la Tourette syndrome	0.00018	0.0205	CrCbGaD
Nortriptyline—Doxepin—HTR2A—Gilles de la Tourette syndrome	0.00018	0.0204	CrCbGaD
Nortriptyline—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.000165	0.0188	CrCbGaD
Nortriptyline—Imipramine—HTR2A—Gilles de la Tourette syndrome	0.00014	0.0159	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—Gilles de la Tourette syndrome	0.000139	0.0158	CrCbGaD
Nortriptyline—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000102	0.00078	CbGpPWpGaD
Nortriptyline—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000101	0.000779	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.93e-05	0.000762	CbGpPWpGaD
Nortriptyline—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.82e-05	0.000754	CbGpPWpGaD
Nortriptyline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.8e-05	0.000752	CbGpPWpGaD
Nortriptyline—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.77e-05	0.000749	CbGpPWpGaD
Nortriptyline—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.74e-05	0.000747	CbGpPWpGaD
Nortriptyline—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.72e-05	0.000746	CbGpPWpGaD
Nortriptyline—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.64e-05	0.00074	CbGpPWpGaD
Nortriptyline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	9.62e-05	0.000738	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.57e-05	0.000734	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.52e-05	0.000731	CbGpPWpGaD
Nortriptyline—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.29e-05	0.000713	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.29e-05	0.000713	CbGpPWpGaD
Nortriptyline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.27e-05	0.000711	CbGpPWpGaD
Nortriptyline—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.24e-05	0.000709	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.24e-05	0.000709	CbGpPWpGaD
Nortriptyline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.24e-05	0.000709	CbGpPWpGaD
Nortriptyline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.21e-05	0.000707	CbGpPWpGaD
Nortriptyline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.14e-05	0.000701	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.12e-05	0.000699	CbGpPWpGaD
Nortriptyline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	9.1e-05	0.000698	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—HDC—Gilles de la Tourette syndrome	8.86e-05	0.00068	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.85e-05	0.000679	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.85e-05	0.000679	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.66e-05	0.000664	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.61e-05	0.000661	CbGpPWpGaD
Nortriptyline—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	8.42e-05	0.000646	CbGpPWpGaD
Nortriptyline—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.4e-05	0.000645	CbGpPWpGaD
Nortriptyline—ALB—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	8.32e-05	0.000639	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.27e-05	0.000634	CbGpPWpGaD
Nortriptyline—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.25e-05	0.000633	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.24e-05	0.000633	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.22e-05	0.000631	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.2e-05	0.000629	CbGpPWpGaD
Nortriptyline—HTR6—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.19e-05	0.000628	CbGpPWpGaD
Nortriptyline—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.16e-05	0.000626	CbGpPWpGaD
Nortriptyline—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.16e-05	0.000626	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.12e-05	0.000623	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	8.1e-05	0.000621	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.03e-05	0.000616	CbGpPWpGaD
Nortriptyline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.01e-05	0.000615	CbGpPWpGaD
Nortriptyline—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.01e-05	0.000615	CbGpPWpGaD
Nortriptyline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.99e-05	0.000613	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.98e-05	0.000613	CbGpPWpGaD
Nortriptyline—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.96e-05	0.000611	CbGpPWpGaD
Nortriptyline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.96e-05	0.000611	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.96e-05	0.000611	CbGpPWpGaD
Nortriptyline—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.92e-05	0.000608	CbGpPWpGaD
Nortriptyline—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.88e-05	0.000605	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.88e-05	0.000605	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	7.86e-05	0.000603	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.86e-05	0.000603	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.86e-05	0.000603	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.73e-05	0.000593	CbGpPWpGaD
Nortriptyline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.58e-05	0.000582	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.48e-05	0.000574	CbGpPWpGaD
Nortriptyline—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.46e-05	0.000573	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.44e-05	0.000571	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.41e-05	0.000569	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.4e-05	0.000568	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.34e-05	0.000563	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.32e-05	0.000562	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.31e-05	0.000561	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.09e-05	0.000544	CbGpPWpGaD
Nortriptyline—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.99e-05	0.000536	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.96e-05	0.000534	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.89e-05	0.000529	CbGpPWpGaD
Nortriptyline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.86e-05	0.000527	CbGpPWpGaD
Nortriptyline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.84e-05	0.000525	CbGpPWpGaD
Nortriptyline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.82e-05	0.000523	CbGpPWpGaD
Nortriptyline—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.75e-05	0.000518	CbGpPWpGaD
Nortriptyline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.73e-05	0.000517	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.69e-05	0.000513	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.64e-05	0.000509	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	6.62e-05	0.000508	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	6.61e-05	0.000507	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.61e-05	0.000507	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.6e-05	0.000507	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.44e-05	0.000494	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.41e-05	0.000492	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.26e-05	0.00048	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.23e-05	0.000478	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.21e-05	0.000476	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.08e-05	0.000466	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.06e-05	0.000465	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.03e-05	0.000463	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.03e-05	0.000462	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6e-05	0.00046	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.99e-05	0.00046	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.97e-05	0.000458	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.82e-05	0.000447	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.77e-05	0.000443	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—HDC—Gilles de la Tourette syndrome	5.69e-05	0.000437	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.66e-05	0.000434	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.64e-05	0.000432	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.61e-05	0.000431	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.47e-05	0.00042	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.42e-05	0.000416	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.41e-05	0.000415	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.38e-05	0.000413	CbGpPWpGaD
Nortriptyline—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.32e-05	0.000408	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.25e-05	0.000403	CbGpPWpGaD
Nortriptyline—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.23e-05	0.000401	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.22e-05	0.000401	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.21e-05	0.0004	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.19e-05	0.000398	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.15e-05	0.000395	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.14e-05	0.000395	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.13e-05	0.000394	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	5.11e-05	0.000392	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.1e-05	0.000391	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5e-05	0.000384	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.91e-05	0.000377	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.89e-05	0.000375	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.89e-05	0.000375	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.87e-05	0.000373	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.77e-05	0.000366	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.75e-05	0.000364	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.74e-05	0.000364	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	4.7e-05	0.000361	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.68e-05	0.000359	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.67e-05	0.000359	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.66e-05	0.000358	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	4.66e-05	0.000358	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.66e-05	0.000357	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.65e-05	0.000357	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.63e-05	0.000356	CbGpPWpGaD
Nortriptyline—HTR6—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.63e-05	0.000355	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.61e-05	0.000354	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.59e-05	0.000352	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.58e-05	0.000351	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.54e-05	0.000348	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.54e-05	0.000348	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.53e-05	0.000347	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.51e-05	0.000346	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.5e-05	0.000345	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.45e-05	0.000342	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.44e-05	0.000341	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.44e-05	0.000341	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.42e-05	0.000339	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.37e-05	0.000335	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.31e-05	0.000331	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.24e-05	0.000326	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.23e-05	0.000325	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.23e-05	0.000325	CbGpPWpGaD
Nortriptyline—ALB—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	4.23e-05	0.000325	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.23e-05	0.000324	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.22e-05	0.000324	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.22e-05	0.000324	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.21e-05	0.000323	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.2e-05	0.000323	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.2e-05	0.000323	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.19e-05	0.000322	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.19e-05	0.000321	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.18e-05	0.000321	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.17e-05	0.00032	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.16e-05	0.000319	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.15e-05	0.000318	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.14e-05	0.000318	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.12e-05	0.000316	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.11e-05	0.000315	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.1e-05	0.000314	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.08e-05	0.000313	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.04e-05	0.00031	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.03e-05	0.00031	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	3.98e-05	0.000306	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.97e-05	0.000304	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.93e-05	0.000302	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.92e-05	0.000301	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.84e-05	0.000294	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.83e-05	0.000294	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.82e-05	0.000293	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.81e-05	0.000292	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.81e-05	0.000292	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.8e-05	0.000291	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.77e-05	0.000289	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.76e-05	0.000288	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.7e-05	0.000284	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.59e-05	0.000275	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.57e-05	0.000274	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.55e-05	0.000272	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.54e-05	0.000272	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.44e-05	0.000264	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.43e-05	0.000263	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.41e-05	0.000262	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.34e-05	0.000257	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.33e-05	0.000255	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.26e-05	0.00025	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.23e-05	0.000248	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.2e-05	0.000246	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.11e-05	0.000239	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.1e-05	0.000238	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	3.07e-05	0.000236	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.01e-05	0.000231	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.01e-05	0.000231	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.96e-05	0.000227	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.95e-05	0.000227	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.94e-05	0.000226	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.93e-05	0.000225	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.91e-05	0.000223	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.9e-05	0.000223	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.9e-05	0.000222	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.89e-05	0.000222	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.82e-05	0.000216	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.8e-05	0.000215	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.76e-05	0.000212	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.73e-05	0.00021	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.68e-05	0.000206	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.68e-05	0.000206	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.67e-05	0.000205	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.67e-05	0.000204	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.64e-05	0.000203	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.63e-05	0.000202	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.62e-05	0.000201	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.61e-05	0.0002	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.55e-05	0.000195	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.51e-05	0.000192	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.5e-05	0.000192	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.5e-05	0.000192	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.49e-05	0.000191	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.49e-05	0.000191	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.48e-05	0.000191	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.47e-05	0.00019	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.46e-05	0.000189	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000188	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.43e-05	0.000187	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.43e-05	0.000186	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.42e-05	0.000186	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.41e-05	0.000185	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.39e-05	0.000183	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000183	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.34e-05	0.00018	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.27e-05	0.000174	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.26e-05	0.000174	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.25e-05	0.000173	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.25e-05	0.000172	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.24e-05	0.000172	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.23e-05	0.000171	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.00017	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.11e-05	0.000162	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.84e-05	0.000141	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.83e-05	0.00014	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.75e-05	0.000134	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.61e-05	0.000124	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000122	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000121	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.57e-05	0.000121	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.56e-05	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.000119	CbGpPWpGaD
